Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

ACADIA Pharmaceuticals Inc. (ACAD) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Trading halt imposed on Bighorn Metals Corp. shares by Canadian regulator CIRO.

The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...

Market News
2 hours ago
Globe Newswire
Neutral
Trading halt imposed on Bighorn Metals Corp. shares by Canadian regulator CIRO.

FDA approves Jemperli as first immunotherapy for advanced MSI-H/dMMR rectal cancer, avoiding chemo and surgery.

The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...

Market News
2 hours ago
Anaptysbio, Inc.
Bullish
news icon
FDA approves Jemperli as first immunotherapy for advanced MSI-H/dMMR rectal cancer, avoiding chemo and surgery.

Ethereum-based crypto Pepeto nears Binance listing as Cardano eyes 6x price rise by 2026

Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...

Market News
3 hours ago
Not Specified
Bullish
news icon
Ethereum-based crypto Pepeto nears Binance listing as Cardano eyes 6x price rise by 2026

Migraine market to grow 6% by 2036 with new therapies beyond CGRP targeting PACAP and TRPA1.

The global migraine market is projected to expand at a 6% annual growth rate through 2036, driven by rising migraine prevalence, better diagnosis, and awareness. Innovative treatments beyond traditional CGRP inhibitors, including PACAP-targeted thera...

Market News
4 hours ago
Delveinsight
Bullish
news icon
Migraine market to grow 6% by 2036 with new therapies beyond CGRP targeting PACAP and TRPA1.

Home Bancorp CEO John Bordelon to retire in 2027; Darren Guidry named successor.

Home Bancorp announced that CEO John W. Bordelon will retire effective January 8, 2027, after over 45 years with the company. Bordelon will remain Chairman and on the boards to support leadership continuity. Darren E. Guidry, currently President sinc...

Market News
4 hours ago
PRNewsWire
Neutral
Home Bancorp CEO John Bordelon to retire in 2027; Darren Guidry named successor.

Stoke Therapeutics eyes 2027 readout for potential first disease-modifying Dravet syndrome therapy.

Stoke Therapeutics is preparing for a key 2027 data readout of zorevunersen, which could become the first disease-modifying treatment for Dravet syndrome. The company has a strong financial position with $420 million in cash and a recent $65.7 millio...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Stoke Therapeutics eyes 2027 readout for potential first disease-modifying Dravet syndrome therapy.

Christopher Whalen exits bank stocks, bets on precious metals amid rising credit risks and Fed easing expectations.

Christopher Whalen, a banking analyst, sold all his bank stocks at the end of September, anticipating rising credit costs and higher consumer loan delinquencies. He shifted his investments toward precious metals like gold and silver, viewing them as ...

Market News
4 hours ago
Kitco
Bearish
news icon
Christopher Whalen exits bank stocks, bets on precious metals amid rising credit risks and Fed easing expectations.

Ball Corp appoints Carey Causey and Scott Vail as new leaders for key beverage packaging units

Ball Corporation announced leadership changes with Carey Causey becoming president of Beverage Packaging North and Central America, and Scott Vail appointed president of Beverage Packaging Europe, Middle East, and Africa. These changes aim to strengt...

Market News
4 hours ago
PRNewsWire
Neutral
Ball Corp appoints Carey Causey and Scott Vail as new leaders for key beverage packaging units

Bitdeer reports 200% rise in Bitcoin production and $2.9B AI cloud backlog with major data center expansions.

Bitdeer Technologies Group announced a 200% year-over-year increase in Bitcoin production to 1,355 Bitcoins and secured over $2.9 billion in AI cloud revenue backlog through major data center expansions in Malaysia and Norway. The company acquired 20...

Market News
4 hours ago
GlobeNewsWire
Bullish
news icon
Bitdeer reports 200% rise in Bitcoin production and $2.9B AI cloud backlog with major data center expansions.

Encompass Health named America's top inpatient rehab leader by Newsweek for 7th year with 78 hospitals recognized.

Encompass Health has been named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh consecutive year, with a record 78 hospitals across 32 states recognized. This distinction highlights the company's commitment to hi...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
Encompass Health named America's top inpatient rehab leader by Newsweek for 7th year with 78 hospitals recognized.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $3.29B
  • Volume
    1,672,256
  • Sector
    Health
  • 52W High
    $30.57
  • 52W Low
    $18.62
  • Typical Hold Time
    77 Days
  • Enterprise Value
    $2.41B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$19.13
52W Low: $18.62
13 Oct 2026
52W High: $30.57
25 Aug 2026

Track ACADIA Pharmaceuticals Inc. (ACAD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ACADIA Pharmaceuticals Inc. has traded between a low of $18.62 and a high of $30.57, highlighting its annual price range. Buy and sell ACADIA Pharmaceuticals Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!